Page last updated: 2024-12-07

alpha-bergamotene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Alpha-bergamotene is a naturally occurring sesquiterpene found in various essential oils, including bergamot, grapefruit, and tea tree oil. It is known for its characteristic woody, citrusy, and slightly spicy aroma. Alpha-bergamotene has been reported to possess antimicrobial and anti-inflammatory properties, which may contribute to the therapeutic benefits of essential oils containing this compound. Studies have investigated its potential as a therapeutic agent for conditions such as skin infections and inflammatory diseases. The synthesis of alpha-bergamotene can be achieved through various methods, including enzymatic and chemical reactions. Its importance lies in its fragrance properties and potential applications in aromatherapy, perfumery, and pharmaceuticals.'

alpha-bergamotene: RR (13434-59-4) refers to the (trans)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

alpha-bergamotene : A sesquiterpene consisting of a bicyclo[3.1.1]hept-2-ene skeleton substituted at positions 2 and 6 by methyl groups and at position 6 by a 4-methylpent-3-en-1-yl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID86608
CHEBI ID62755
MeSH IDM0384434

Synonyms (21)

Synonym
2-norpinene, 2,6-dimethyl-6-(4-methyl-3-pentenyl)-
bicyclo[3.1.1]hept-2-ene, 2,6-dimethyl-6-(4-methyl-3-pentenyl)-
2-norpinene, 2,6-dimethyl-6-(4-methyl-3-pentenyl)
C17088
17699-05-7
alpha-bergamotene
CHEBI:62755
2,6-dimethyl-6-(4-methylpent-3-en-1-yl)bicyclo[3.1.1]hept-2-ene
2,6-dimethyl-6-(4-methyl-3-pentenyl)bicyclo(3.1.1)hept-2-ene
bicyclo(3.1.1)hept-2-ene, 2,6-dimethyl-6-(4-methyl-3-pentenyl)-
einecs 241-702-9
FT-0622209
alpha-trans-bergamotene
.alpha.-bergamotene
2,6-dimethyl-6-(4-methyl-3-pentenyl)bicyclo[3.1.1]hept-2-ene #
2,6-dimethyl-6-(4-methyl-3-pentenyl)bicyclo[3.1.1]hept-2-ene
alpha-bergam0tene
2,6-dimethyl-6-(4-methylpent-3-enyl)bicyclo[3.1.1]hept-2-ene
Q27132146
2,6-dimethyl-6-(4-methyl-3-penten-1-yl)bicyclo[3.1.1]hept-2-ene
DTXSID90864411
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
bridged compoundA polycyclic compound in which two rings have two or more atoms in common.
sesquiterpeneA C15 terpene.
polycyclic olefinA polycyclic hydrocarbon having any number of double bonds.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (33.33)29.6817
2010's16 (59.26)24.3611
2020's2 (7.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.73 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]